AIMS/HYPOTHESIS: We studied the associations of size at birth and prematurity with type 2 diabetes, insulin sensitivity and beta cell function in the Danish population-based Inter99 study (ClinicalTrials.gov NCT00289237). METHODS: Information about size at birth and prematurity was identified from original midwife records in 4,744 middle-aged Danes. Type 2 diabetes status, insulin sensitivity (Matsuda index) and beta cell function (disposition index) were assessed using a 75 g oral glucose tolerance test. Participants born prematurely were compared with a group of at-term participants born small for gestational age. RESULTS: An increase in birthweight of 1 kg was associated with a 51% (OR 0.49, 95% CI 0.35-0.69) reduced risk of type 2 diabetes. Ponderal index, reflecting thinness at birth, was associated with type 2 diabetes to the same extent as birthweight. The prevalence of type 2 diabetes was increased to a similar degree in participants born prematurely and participants born small for gestational age, although the former had a higher ponderal index at birth. In addition, birthweight z-scores, reflecting fetal growth rate, were unrelated to the risk of type 2 diabetes and to other measures of glucose regulation in participants born prematurely. While low birthweight was inversely associated with insulin sensitivity and beta cell function, prematurity was associated solely with decreased insulin sensitivity. CONCLUSIONS/ INTERPRETATION: While the association between birthweight and risk of type 2 diabetes is mediated via combined effects on beta cell function and insulin sensitivity, prematurity seems to influence risk of type 2 diabetes via attenuated insulin sensitivity only and independently of fetal growth rates.
AIMS/HYPOTHESIS: We studied the associations of size at birth and prematurity with type 2 diabetes, insulin sensitivity and beta cell function in the Danish population-based Inter99 study (ClinicalTrials.gov NCT00289237). METHODS: Information about size at birth and prematurity was identified from original midwife records in 4,744 middle-aged Danes. Type 2 diabetes status, insulin sensitivity (Matsuda index) and beta cell function (disposition index) were assessed using a 75 g oral glucose tolerance test. Participants born prematurely were compared with a group of at-term participants born small for gestational age. RESULTS: An increase in birthweight of 1 kg was associated with a 51% (OR 0.49, 95% CI 0.35-0.69) reduced risk of type 2 diabetes. Ponderal index, reflecting thinness at birth, was associated with type 2 diabetes to the same extent as birthweight. The prevalence of type 2 diabetes was increased to a similar degree in participants born prematurely and participants born small for gestational age, although the former had a higher ponderal index at birth. In addition, birthweight z-scores, reflecting fetal growth rate, were unrelated to the risk of type 2 diabetes and to other measures of glucose regulation in participants born prematurely. While low birthweight was inversely associated with insulin sensitivity and beta cell function, prematurity was associated solely with decreased insulin sensitivity. CONCLUSIONS/ INTERPRETATION: While the association between birthweight and risk of type 2 diabetes is mediated via combined effects on beta cell function and insulin sensitivity, prematurity seems to influence risk of type 2 diabetes via attenuated insulin sensitivity only and independently of fetal growth rates.
Authors: K Pilgaard; K Færch; P Poulsen; C Larsen; E A Andersson; C Pisinger; U Toft; M Aadahl; O Pedersen; T Hansen; K Borch-Johnsen; A Vaag; T Jørgensen Journal: J Dev Orig Health Dis Date: 2010-10 Impact factor: 2.401
Authors: Paul L Hofman; Fiona Regan; Wendy E Jackson; Craig Jefferies; David B Knight; Elizabeth M Robinson; Wayne S Cutfield Journal: N Engl J Med Date: 2004-11-18 Impact factor: 91.245
Authors: Magnus Kaijser; Anna-Karin Edstedt Bonamy; Olof Akre; Sven Cnattingius; Fredrik Granath; Mikael Norman; Anders Ekbom Journal: Diabetes Date: 2008-12-09 Impact factor: 9.461
Authors: Linn Gillberg; Alexander Perfilyev; Charlotte Brøns; Martin Thomasen; Louise G Grunnet; Petr Volkov; Fredrik Rosqvist; David Iggman; Ingrid Dahlman; Ulf Risérus; Tina Rönn; Emma Nilsson; Allan Vaag; Charlotte Ling Journal: Diabetologia Date: 2016-01-11 Impact factor: 10.122
Authors: Guoying Wang; Sara Divall; Sally Radovick; David Paige; Yi Ning; Zhu Chen; Yuelong Ji; Xiumei Hong; Sheila O Walker; Deanna Caruso; Colleen Pearson; Mei-Cheng Wang; Barry Zuckerman; Tina L Cheng; Xiaobin Wang Journal: JAMA Date: 2014-02-12 Impact factor: 56.272